Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $62,750 | 27 | 98.2% |
| Food and Beverage | $1,146 | 10 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $36,900 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23,000 | 7 | $0 (2020) |
| PFIZER INC. | $2,897 | 2 | $0 (2019) |
| KOWA COMPANY, LTD. | $980.78 | 6 | $0 (2019) |
| AstraZeneca UK Limited | $118.17 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,000 | 1 | CSL Behring ($3,000) |
| 2023 | $6,000 | 2 | CSL Behring ($6,000) |
| 2022 | $9,450 | 7 | CSL Behring ($9,450) |
| 2021 | $11,760 | 7 | CSL Behring ($11,760) |
| 2020 | $3,000 | 1 | AstraZeneca Pharmaceuticals LP ($3,000) |
| 2019 | $17,977 | 11 | AstraZeneca Pharmaceuticals LP ($8,000) |
| 2018 | $6,384 | 5 | AstraZeneca Pharmaceuticals LP ($6,000) |
| 2017 | $6,326 | 3 | AstraZeneca Pharmaceuticals LP ($6,000) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 07/24/2023 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 07/24/2023 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 07/14/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 07/14/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 07/14/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 07/14/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 07/14/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 07/14/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 07/14/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 05/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 05/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 05/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 05/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 05/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 05/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 05/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 01/10/2020 | AstraZeneca Pharmaceuticals LP | EPANOVA (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2019 | KOWA COMPANY, LTD. | — | Food and Beverage | Cash or cash equivalent | $244.49 | General |
| 12/17/2019 | KOWA COMPANY, LTD. | — | Food and Beverage | Cash or cash equivalent | $26.55 | General |
| 11/25/2019 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $3,690.00 | General |
| 10/18/2019 | AstraZeneca Pharmaceuticals LP | EPANOVA (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/01/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,850.00 | General |
| 06/03/2019 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $47.30 | General |
| 04/04/2019 | AstraZeneca Pharmaceuticals LP | EPANOVA (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. Frank Sacks, MD
Dr. Frank Sacks, MD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124081542.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Sacks, MD has received a total of $63,896 in payments from pharmaceutical and medical device companies, with $3,000 received in 2024. These payments were reported across 37 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($62,750).
Practice Information
- Specialty Internal Medicine
- Location Boston, MA
- Active Since 04/07/2006
- Last Updated 08/20/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124081542
Products in Payments
- EPANOVA (Drug) $23,118
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M